{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T08:26:28Z","timestamp":1788251188983,"version":"build-2803163510"},"reference-count":82,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007248","name":"Mind Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007248","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["F30AI150061"],"award-info":[{"award-number":["F30AI150061"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K08AR074556"],"award-info":[{"award-number":["K08AR074556"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001582","name":"Dermatology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","theclinics.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.det.2021.05.008","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T22:06:26Z","timestamp":1626991586000},"page":"533-543","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease"],"prefix":"10.1016","volume":"39","author":[{"given":"Antonia E.","family":"Gallman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlys S.","family":"Fassett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib1","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1016\/j.jaad.2020.06.1016","article-title":"The spectrum of COVID-19\u2013associated dermatologic manifestations: An international registry of 716 patients from 31 countries","volume":"83","author":"Freeman","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.05.008_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.jaad.2020.05.059","article-title":"Cutaneous manifestations of COVID-19: A preliminary review","volume":"83","author":"Jia","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib3","article-title":"Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 can be Divided Into Inflammatory and Vascular Patterns","volume":"7","author":"Naderi-Azad","year":"2020","journal-title":"J\u00a0Cutan Med Surg"},{"issue":"9","key":"10.1016\/j.det.2021.05.008_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jamadermatol.2020.2800","article-title":"Livedoid and Purpuric Skin Eruptions Associated With Coagulopathy in Severe COVID-19","volume":"156","author":"Droesch","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib5","first-page":"302","article-title":"Clinical and coagulation characteristics in 7 patients with critical COVID-2019 pneumonia and acro-ischemia","volume":"41","author":"Zhang","year":"2020","journal-title":"Chin J Hematol"},{"issue":"17","key":"10.1016\/j.det.2021.05.008_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMc2007575","article-title":"Coagulopathy and Antiphospholipid Antibodies in Patients with Covid-19","volume":"382","author":"Zhang","year":"2020","journal-title":"N\u00a0Engl J Med"},{"issue":"11","key":"10.1016\/j.det.2021.05.008_bib7","doi-asserted-by":"crossref","first-page":"e679","DOI":"10.1111\/jdv.16763","article-title":"Catastrophic acute bilateral lower limbs necrosis associated with COVID-19 as a likely consequence of both vasculitis and coagulopathy","volume":"34","author":"Del Giudice","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.det.2021.05.008_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.trsl.2020.04.007","article-title":"Complement associated microvascular injury and thrombosis in the pathogenesis of severe COVID-19 infection: A report of five cases","volume":"220","author":"Magro","year":"2020","journal-title":"Translational Res"},{"issue":"11","key":"10.1016\/j.det.2021.05.008_bib9","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1111\/jdv.16682","article-title":"A\u00a0clinical, histopathological and laboratory study of 19 consecutive Italian paediatric patients with chilblain-like lesions: lights and shadows on the relationship with COVID-19 infection","volume":"34","author":"Hachem El","year":"2020","journal-title":"J\u00a0Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib10","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.jaad.2020.04.093","article-title":"Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak","volume":"83","author":"Fernandez-Nieto","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.008_bib11","first-page":"1","article-title":"Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic","author":"Hubiche","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.det.2021.05.008_bib12","first-page":"1","article-title":"Adaptive immunity to SARS-CoV-2 and COVID-19","author":"Sette","year":"2021","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib13","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/bjd.19415","article-title":"The differing pathophysiologies that underlie COVID-19-associated perniosis and thrombotic retiform purpura: a case series","volume":"184","author":"Magro","year":"2021","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.008_bib14","doi-asserted-by":"crossref","first-page":"e438","DOI":"10.1016\/S2352-3026(20)30145-9","article-title":"Coagulation abnormalities and thrombosis in patients with COVID-19","volume":"7","author":"Levi","year":"2020","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.det.2021.05.008_bib15","doi-asserted-by":"crossref","first-page":"151645","DOI":"10.1016\/j.anndiagpath.2020.151645","article-title":"Severe COVID-19: A multifaceted viral vasculopathy syndrome","volume":"50","author":"Magro","year":"2021","journal-title":"Ann Diagn Pathol"},{"issue":"9","key":"10.1016\/j.det.2021.05.008_bib16","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.116.306853","article-title":"Cross Talk Pathways Between Coagulation and Inflammation","volume":"118","author":"Foley","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.det.2021.05.008_bib17","series-title":"Janeway's immunobiology","author":"Murphy","year":"2012"},{"key":"10.1016\/j.det.2021.05.008_bib18","first-page":"1","article-title":"Antibody responses to SARS-CoV-2 in patients with COVID-19","author":"Long","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.det.2021.05.008_bib19","first-page":"1","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","author":"Robbiani","year":"2020","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib20","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.cell.2020.11.029","article-title":"Functional SARS-CoV-2-Specific Immune Memory Persists after Mild COVID-19","volume":"184","author":"Rodda","year":"2021","journal-title":"Cell"},{"issue":"577","key":"10.1016\/j.det.2021.05.008_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abf1555","article-title":"Enhanced SARS-CoV-2 neutralization by dimeric IgA","volume":"13","author":"Wang","year":"2021","journal-title":"Sci Translational Med"},{"issue":"577","key":"10.1016\/j.det.2021.05.008_bib22","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abd2223","article-title":"IgA dominates the early neutralizing antibody response to SARS-CoV-2","volume":"13","author":"Sterlin","year":"2021","journal-title":"Sci Translational Med"},{"key":"10.1016\/j.det.2021.05.008_bib23","first-page":"1","article-title":"Comment Long COVID in the skin: a registry analysis of COVID-19 dermatological duration","author":"McMahon","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.det.2021.05.008_bib24","doi-asserted-by":"crossref","DOI":"10.1126\/science.abf4063","article-title":"Immunological memory to SARS-CoV-2 assessed for up to 8 months after infection","author":"Dan","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.det.2021.05.008_bib25","first-page":"1","article-title":"Evolution of antibody immunity to SARS-CoV-2","author":"Gaebler","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.det.2021.05.008_bib26","doi-asserted-by":"crossref","first-page":"102592","DOI":"10.1016\/j.jaut.2020.102592","article-title":"The JANUS of chronic inflammatory and autoimmune diseases onset during COVID-19 \u2013 A systematic review of the literature","volume":"117","author":"Novelli","year":"2021","journal-title":"J\u00a0Autoimmun"},{"key":"10.1016\/j.det.2021.05.008_bib27","first-page":"1","article-title":"Role of Infectious Diseases in the Antiphospholipid Syndrome (Including Its Catastrophic Variant)","author":"Mendoza-Pinto","year":"2018","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib28","doi-asserted-by":"crossref","first-page":"314","DOI":"10.3109\/08830185.2014.917411","article-title":"Rheumatic Fever, Autoimmunity, and Molecular Mimicry: The Streptococcal Connection","volume":"33","author":"Cunningham","year":"2014","journal-title":"Int Rev Immunol"},{"key":"10.1016\/j.det.2021.05.008_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.3389\/fimmu.2019.00449","article-title":"Complement in the Pathophysiology of the Antiphospholipid Syndrome","volume":"10","author":"Chaturvedi","year":"2019","journal-title":"Front Immunol"},{"issue":"12","key":"10.1016\/j.det.2021.05.008_bib30","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/art.41425","article-title":"Antiphospholipid Antibodies in Critically Ill Patients With COVID-19","volume":"72","author":"Xiao","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"570","key":"10.1016\/j.det.2021.05.008_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1126\/scitranslmed.abd3876","article-title":"Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19","volume":"12","author":"Zuo","year":"2020","journal-title":"Sci Translational Med"},{"issue":"2","key":"10.1016\/j.det.2021.05.008_bib32","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s12016-007-0004-0","article-title":"Livedo Reticularis as a Criterion for Antiphospholipid Syndrome","volume":"32","author":"Toubi","year":"2007","journal-title":"Clinic Rev Allerg Immunol"},{"key":"10.1016\/j.det.2021.05.008_bib33","first-page":"1","article-title":"Mucocutaneous Manifestations of Multisystem Inflammatory Syndrome in Children During the COVID-19 Pandemic","author":"Young","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib34","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C)","volume":"183","author":"Gruber","year":"2020","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib35","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.cell.2020.09.016","article-title":"The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19","volume":"183","author":"Consiglio","year":"2020","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.det.2021.05.008_bib36","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.immuni.2021.04.003","article-title":"Immune dysregulation and autoreactivity correlate with disease severity in SARS-CoV-2-associated multisystem inflammatory syndrome in children.","volume":"54","author":"Ramaswamy","year":"2021","journal-title":"Immunity"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib37","doi-asserted-by":"crossref","first-page":"251","DOI":"10.18176\/jiaci.0300","article-title":"Autoimmune Aspects of Kawasaki Disease","volume":"29","author":"Sakurai","year":"2019","journal-title":"J\u00a0Investig Allergol Clin Immunol"},{"issue":"10","key":"10.1016\/j.det.2021.05.008_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJMra993360","article-title":"Immunomodulation of autoimmune and inflammatory diseases with intravenous immune globulin","volume":"345","author":"Kazatchkine","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.det.2021.05.008_bib39","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.4049\/jimmunol.1003526","article-title":"Functional Characteristics of the High Affinity IgG Receptor, Fc\u03b3RI","volume":"186","author":"van der Poel","year":"2011","journal-title":"J\u00a0Immunol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib40","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.4049\/jimmunol.0801683","article-title":"Activation of Fc\u03b3RI on Monocytes Triggers Differentiation into Immature Dendritic Cells That Induce Autoreactive T Cell Responses","volume":"183","author":"Tanaka","year":"2009","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.det.2021.05.008_bib41","article-title":"Diverse Functional Autoantibodies in Patients with COVID-19","author":"Wang","year":"2021","journal-title":"Nature"},{"issue":"6","key":"10.1016\/j.det.2021.05.008_bib42","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1001\/jamaneurol.2020.1127","article-title":"Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China","volume":"77","author":"Mao","year":"2020","journal-title":"JAMA Neurol"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib43","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/imr.12091","article-title":"Virus infection, antiviral immunity, and autoimmunity","volume":"255","author":"Getts","year":"2013","journal-title":"Immunol Rev"},{"key":"10.1016\/j.det.2021.05.008_bib44","first-page":"71","article-title":"Acute acro-ischemia in the child at the time of COVID-19","volume":"30","author":"Mazzotta","year":"2020","journal-title":"Eur J Pediat Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.05.008_bib45","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.ad.2020.04.002","article-title":"Chilblain and Acral Purpuric Lesions in Spain during Covid Confinement: Retrospective Analysis of 12 Cases","volume":"111","author":"Roman\u00ed","year":"2020","journal-title":"Actas Dermosifiliogr"},{"issue":"6","key":"10.1016\/j.det.2021.05.008_bib46","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/ced.14243","article-title":"Two cases of COVID-19 presenting with a clinical picture resembling chilblains: first report from the Middle East","volume":"45","author":"Alramthan","year":"2020","journal-title":"Clin Exp Dermatol"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib47","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/bjd.19163","article-title":"Classification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases","volume":"183","author":"Galv\u00e1n Casas","year":"2020","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.008_bib48","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/jamadermatol.2020.2368","article-title":"Evaluation of Chilblains as a Manifestation of the COVID-19 Pandemic","volume":"156","author":"Herman","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"9","key":"10.1016\/j.det.2021.05.008_bib49","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1001\/jamadermatol.2020.2340","article-title":"Assessment of Acute Acral Lesions in a Case Series of Children and Adolescents During the COVID-19 Pandemic","volume":"156","author":"Roca-Gin\u00e9s","year":"2020","journal-title":"JAMA Dermatol"},{"issue":"5","key":"10.1016\/j.det.2021.05.008_bib50","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.jaad.2020.07.048","article-title":"Lack of association between chilblains outbreak and severe acute respiratory syndrome coronavirus 2: Histologic and serologic findings from a new immunoassay","volume":"83","author":"H\u00e9bert","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib51","first-page":"729","article-title":"All that glisters is not COVID: Low prevalence of seroconversion against SARS-CoV-2 in a pediatric cohort of patients with chilblain-like lesions","volume":"183","author":"Denina","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"7","key":"10.1016\/j.det.2021.05.008_bib52","first-page":"1","article-title":"Evaluation of SARS-CoV-2 antibodies in 24 patients presenting with chilblains-like lesions during the COVID-19 pandemic","volume":"34","author":"Stavert","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1111\/bjd.19327","article-title":"SARS-CoV-2 endothelial infection causes COVID-19 chilblains: histopathological, immunohistochemical and ultrastructural study of seven paediatric cases","volume":"183","author":"Colmenero","year":"2020","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.05.008_bib54","first-page":"1","article-title":"Evaluation of SARS-CoV-2 serology assays reveals a range of test performance","author":"Whitman","year":"2020","journal-title":"Nat Biotechnol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib55","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.jaad.2020.06.1018","article-title":"New insights in COVID-19 associated chilblains: A comparative study with chilblain lupus erythematosus","volume":"83","author":"Battesti","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2021.05.008_bib56","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/j.jaad.2020.04.161","article-title":"Chilblains is a common cutaneous finding during the COVID-19 pandemic: A retrospective nationwide study from France","volume":"83","author":"de Masson","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2021.05.008_bib57","first-page":"1","article-title":"Histopathological features of Chilblain-like lesions developing in the setting of the COVID-19 pandemic","author":"Sohier","year":"2020","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"10.1016\/j.det.2021.05.008_bib58","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jaad.2020.05.145","article-title":"Chilblain-like acral lesions during the COVID-19 pandemic (\u201cCOVID toes\u201d): Histologic, immunofluorescence, and immunohistochemical study of 17 cases","volume":"83","author":"Kanitakis","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2021.05.008_bib59","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/pde.14227","article-title":"Clustered cases of acral perniosis: Clinical features, histopathology, and relationship to COVID-19","volume":"37","author":"Cordoro","year":"2020","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.det.2021.05.008_bib60","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jdcr.2020.04.011","article-title":"Coronavirus (COVID-19) infection-induced chilblains: A case report with histopathologic findings","volume":"6","author":"Kolivras","year":"2020","journal-title":"JAAD Case Rep"},{"key":"10.1016\/j.det.2021.05.008_bib61","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1093\/bmb\/ldn049","article-title":"Aicardi-Goutieres syndrome","volume":"89","author":"Orcesi","year":"2009","journal-title":"Br Med Bull"},{"key":"10.1016\/j.det.2021.05.008_bib62","doi-asserted-by":"crossref","DOI":"10.1111\/bjd.19894","article-title":"Cold and COVID: Recurrent Pernio during the COVID-19 Pandemic","author":"Freeman","year":"2021","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2021.05.008_bib63","first-page":"1","article-title":"Deregulated Type I IFN Response in TREX1-Associated Familial Chilblain","author":"Peschke","year":"2010","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib64","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1001\/jamadermatol.2014.3438","article-title":"Familial Chilblain Lupus Due to a Novel Mutation in the Exonuclease III Domain of 3\u2032 Repair Exonuclease 1 ( TREX1)","volume":"151","author":"G\u00fcnther","year":"2015","journal-title":"JAMA Dermatol"},{"issue":"4","key":"10.1016\/j.det.2021.05.008_bib65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.cell.2008.06.032","article-title":"Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity","volume":"134","author":"Stetson","year":"2008","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.det.2021.05.008_bib66","doi-asserted-by":"crossref","first-page":"e269","DOI":"10.1016\/j.jaad.2020.06.052","article-title":"When interferon tiptoes through COVID-19: Pernio-like lesions and their prognostic implications during SARS-CoV-2 infection","volume":"83","author":"Damsky","year":"2020","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.det.2021.05.008_bib67","doi-asserted-by":"crossref","first-page":"5459","DOI":"10.4049\/jimmunol.1002795","article-title":"Type I Interferon in the Pathogenesis of Lupus","volume":"192","author":"Crow","year":"2014","journal-title":"J\u00a0Immunol"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib68","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaci.2020.04.029","article-title":"Type I IFN immunoprofiling in COVID-19 patients","volume":"146","author":"Trouillet-Assant","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6504","key":"10.1016\/j.det.2021.05.008_bib69","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.abc6027","article-title":"Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients","volume":"369","author":"Hadjadj","year":"2020","journal-title":"Science"},{"issue":"6515","key":"10.1016\/j.det.2021.05.008_bib70","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4570","article-title":"Inborn errors of type I IFN immunity in patients with life-threatening COVID-19","volume":"370","author":"Zhang","year":"2020","journal-title":"Science"},{"issue":"6515","key":"10.1016\/j.det.2021.05.008_bib71","doi-asserted-by":"crossref","DOI":"10.1126\/science.abd4585","article-title":"Autoantibodies against type I IFNs in patients with life-threatening COVID-19","volume":"370","author":"Bastard","year":"2020","journal-title":"Science"},{"issue":"7834","key":"10.1016\/j.det.2021.05.008_bib72","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/d41586-020-03070-1","article-title":"Interferon deficiency can lead to severe COVID","volume":"587","author":"Meffre","year":"2020","journal-title":"Nature"},{"issue":"5361","key":"10.1016\/j.det.2021.05.008_bib73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1126\/science.280.5361.248","article-title":"Viral Strategies of Immune Evasion","volume":"280","author":"Ploegh","year":"1998","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.det.2021.05.008_bib74","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.cell.2020.04.026","article-title":"Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19","volume":"181","author":"Blanco-Melo","year":"2020","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.det.2021.05.008_bib75","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1182\/blood-2016-05-715987","article-title":"Type I interferon causes thrombotic microangiopathy by a dose-dependent toxic effect on the microvasculature","volume":"128","author":"Kavanagh","year":"2016","journal-title":"Blood"},{"issue":"13","key":"10.1016\/j.det.2021.05.008_bib76","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1177\/1352458514523692","article-title":"Thrombotic thrombocytopenic purpura-hemolytic uremic syndrome in relapsing-remitting multiple sclerosis patients on high-dose interferon \u03b2","volume":"20","author":"Larochelle","year":"2014","journal-title":"Mult Scler"},{"issue":"13","key":"10.1016\/j.det.2021.05.008_bib77","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1056\/NEJMc1316118","article-title":"Thrombotic Microangiopathy Associated with Interferon Beta","volume":"370","author":"Hunt","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib78","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.cmi.2020.09.023","article-title":"Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study","volume":"27","author":"Xiong","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"1","key":"10.1016\/j.det.2021.05.008_bib79","doi-asserted-by":"crossref","first-page":"e000755","DOI":"10.1161\/JAHA.113.000755","article-title":"Autoimmune basis for postural tachycardia syndrome","volume":"3","author":"Li","year":"2014","journal-title":"JAHA"},{"issue":"7","key":"10.1016\/j.det.2021.05.008_bib80","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/europace\/euw154","article-title":"Antiadrenergic autoimmunity in postural tachycardia syndrome","volume":"19","author":"Fedorowski","year":"2016","journal-title":"EP Europace"},{"issue":"8","key":"10.1016\/j.det.2021.05.008_bib81","doi-asserted-by":"crossref","first-page":"e008351","DOI":"10.1161\/JAHA.117.008351","article-title":"Angiotensin II Type 1 Receptor Autoantibodies in Postural Tachycardia Syndrome","volume":"7","author":"Yu","year":"2018","journal-title":"JAHA"},{"key":"10.1016\/j.det.2021.05.008_bib82","article-title":"Charting a Covid-19 Immune Response","author":"Wu","year":"2020","journal-title":"The New York Times"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863521000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T02:06:35Z","timestamp":1718762795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863521000450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":82,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S0733863521000450"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2021.05.008","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cutaneous Pathology of COVID-19 as a Window into Immunologic Mechanisms of Disease","name":"articletitle","label":"Article Title"},{"value":"Dermatologic Clinics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.det.2021.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}